Ningbo Konfoong Bioinformation Tech Co., Ltd.

KFBIO, the innovative national high-tech enterprise, one of the few advocates of the end-to-end digital pathology solution in China, is devoted to digital pathology. KFBIO has been in the digital pathology industry for over ten years, and has developed five business segments including the digital pathology slide scanners, telepathology platform, pathology AI, routine pathology equipment and pathology diagnosis services, providing the most complete end-to-end digital pathology solution to meet different needs of customers.

KFBIO was founded by a team of talents back from Japanese. The core technical staff have more than 20 years of research and development experience in image processing and precise movement control. At present, the company has more than 200 employees, including 2 "Chinese Thousand Talents", 1 "Zhejiang Thousand Talents", over 100 R&D personnel specializing in hardware and software development.

As a technology-oriented high-tech enterprise, KFBIO has set up four major R&D centers in China, and has carried out deep cooperation with Intel, Huawei, Nanjing University of Science and Technology, China Maternal and Child Health Association, Tokyo Institute of Technology, etc.

KFBIO digital pathology slide scanner uses line scanning technology and achieves nano-level positioning accuracy, which can finish scanning a 15mm*15mm area at 20 magnification within 15s and produce high-quality and high-resolution images efficiently, suitable for routine diagnosis and intraoperative frozen section diagnosis, with quite competitive price.

KFBIO has dedicated pathology and R&D professionals all over the world. Our personnel is professionally trained to provide fast assistance. We are committed to developing pathological diagnostics and using digital pathology to help humanity.

Excellentfeed back in Chinese market: For example cooperate with KingMed

Enormous remote diagnosis cases: By using all the instruments of our company in the market in 2017, achieve 130, 567 diagnosis cases, which 12, 056 frozen diagnosis cases is included. The pathology solution of KFBIO is safe, complete and steady.

The great R&D group and technical personnel.

So far, more than 40 Remote Diagnosis Platforms have been built by KFBIO in China. We have also built two platform linked with foreign countries:

Platform of University of Pittsburgh Medical Centerlinked with Xiangya Hospital,

Platform of Second Affiliated Hospital of ZhejiangUniversity linked with Chinese American Pathologists Association (CAPA)

We had applied for more than 150 patents, and 74 patents have been authourized.

EN ISO 13485: 2016 qualified.

Company: NINGBO KONFOONG BIOINFORMATION TECH Co., Ltd.

Address: 3F, No. 4Building, Yuyao Technology Innovation Center ZheJiang P. R. C

Contact: Kevin Gui